| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8528241 | Clinical Therapeutics | 2018 | 12 Pages |
Abstract
The IsaGenesis soft gel formulation provided substantially greater absorption and bioavailability of silybin A and silybin B relative to the powdered Product B supplement. ClinicalTrials.gov Identifier: NCT02529605.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Wen-Yi MS, Guo PhD, Renee M. ARNP, Rajesh MD, Reginald F. PharmD, PhD, Eric PhD, John S. PharmD,